Back to Aberdeen Group plc Aberdeen Group plc

GPCRGPCR
Showing 8 of 9 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in STRUCTURE THERAPEUTICS INC

Aberdeen Group plc holds 639,915 shares of GPCR (STRUCTURE THERAPEUTICS INC), worth $34.3M as of 2026-Q2. The position was increased (+63.3% shares). GPCR represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$34.3M

Current Shares

639,915

Total Value Change

+$24.8M

Total Shares Change

+422,832

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
639,915
+63.3%
$34.3M0.0%$53.67
42
2026-Q1
Increased
391,809
+47.9%
$18.9M0.0%$63.03
39
2025-Q4
Decreased
264,869
-54.9%
$18.4M0.0%$67.78
0
2025-Q3
Increased
586,869
+46.1%
$16.4M0.0%$25.30
38
2025-Q2
Increased
401,624
+61.4%
$8.3M0.0%$21.08
40
2025-Q1
Increased
248,899
+45.2%
$4.3M0.0%$19.77
36
2024-Q4
Decreased
171,388
-21.1%
$4.6M0.0%$26.63
0
2024-Q3
Increased
217,083
+132.7%
$9.5M0.0%$41.75
45

Other major holders of GPCR: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used